{
"info": {
"nct_id": "NCT01102231",
"official_title": "Phase II Study of Pemetrexed + Cetuximab + Cisplatin With Concurrent Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)",
"inclusion_criteria": "* non-squamous stage III non-small cell lung cancer\n* measurable disease (RECIST 1.1)\n* ECOG performance status 0-1\n* normal organ and marrow function\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 70 Years",
"exclusion_criteria": "* prior chest radiation therapy\n* history of any cancer other than NSCLC (except non-melanoma skin cancer or carcinoma in situ of the cervix) within the last five years.\n* Prior therapy with known specific inhibitors of the EGFR.\n* history of severe allergic reaction to prior therapy with monoclonal antibodies",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* non-squamous stage III non-small cell lung cancer",
"criterions": [
{
"exact_snippets": "non-squamous",
"criterion": "cancer type",
"requirements": [
{
"requirement_type": "specificity",
"expected_value": "non-squamous"
}
]
},
{
"exact_snippets": "stage III",
"criterion": "cancer stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "III"
}
]
},
{
"exact_snippets": "non-small cell lung cancer",
"criterion": "cancer type",
"requirements": [
{
"requirement_type": "specificity",
"expected_value": "non-small cell lung cancer"
}
]
}
]
},
{
"line": "* measurable disease (RECIST 1.1)",
"criterions": [
{
"exact_snippets": "measurable disease (RECIST 1.1)",
"criterion": "measurable disease",
"requirements": [
{
"requirement_type": "criteria",
"expected_value": "RECIST 1.1"
}
]
}
]
},
{
"line": "* ECOG performance status 0-1",
"criterions": [
{
"exact_snippets": "ECOG performance status 0-1",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* normal organ and marrow function",
"criterions": [
{
"exact_snippets": "normal organ",
"criterion": "organ function",
"requirements": [
{
"requirement_type": "functionality",
"expected_value": "normal"
}
]
},
{
"exact_snippets": "normal ... marrow function",
"criterion": "marrow function",
"requirements": [
{
"requirement_type": "functionality",
"expected_value": "normal"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 70 Years",
"criterions": [
{
"exact_snippets": "maximum age of 70 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 70,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* prior chest radiation therapy",
"criterions": [
{
"exact_snippets": "prior chest radiation therapy",
"criterion": "chest radiation therapy",
"requirements": [
{
"requirement_type": "prior",
"expected_value": true
}
]
}
]
},
{
"line": "* history of any cancer other than NSCLC (except non-melanoma skin cancer or carcinoma in situ of the cervix) within the last five years.",
"criterions": [
{
"exact_snippets": "history of any cancer other than NSCLC",
"criterion": "history of cancer",
"requirements": [
{
"requirement_type": "type",
"expected_value": "any cancer other than NSCLC"
},
{
"requirement_type": "time frame",
"expected_value": "within the last five years"
}
]
},
{
"exact_snippets": "except non-melanoma skin cancer or carcinoma in situ of the cervix",
"criterion": "cancer type exception",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"non-melanoma skin cancer",
"carcinoma in situ of the cervix"
]
}
]
}
]
},
{
"line": "* Prior therapy with known specific inhibitors of the EGFR.",
"criterions": [
{
"exact_snippets": "Prior therapy with known specific inhibitors of the EGFR",
"criterion": "prior therapy with EGFR inhibitors",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* history of severe allergic reaction to prior therapy with monoclonal antibodies",
"criterions": [
{
"exact_snippets": "history of severe allergic reaction to prior therapy with monoclonal antibodies",
"criterion": "severe allergic reaction to monoclonal antibodies",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}